This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Case Western Reserve University's Office of Research Administration Division, doing business as University Hospitals of Cleveland, with a ceiling value of $15,729,937.34. The contract is for tuberculosis trials and consortium services over a 10-year period of performance from January 1, 2021 to December 31, 2030. There is no set-aside designation for this award. The contract requires the vendor to...
This is a definitive federal contract awarded by the Centers for Disease Control and Prevention (CDC) to King County, doing business as Public Health-Seattle & King County, for tuberculosis trials and consortium services. The $10,667,136.30 cost-no-fee contract runs from January 1, 2021 through December 31, 2030. The contract requires King County to participate in the Tuberculosis Trials Consortium and perform various clinical research activities, including screening, enrollment,...
This $3,015,216.50 Delivery Order contract was awarded to Denver Health and Hospital Authority (Denver Health) by the Centers for Disease Control and Prevention (CDC) to provide Vaccine Safety Datalink (VSD) services. The VSD is an IDIQ contract vehicle managed by the CDC to support ongoing vaccine safety monitoring and research. This award does not have a set-aside designation. As a 555-bed academic health system and the region's only Level I trauma center, Denver Health provides...
This federal contract award to Denver Health and Hospital Authority, doing business as Denver Health, is a $2,100,000 firm fixed price delivery order for "ARRA::YES::ARRA TAS::75 1701::TAS RECOVERY ACTION - COMPARATIVE EFFECTIVENESS OF HEALTH DELIVERY SYSTEMS FOR AMERICAN INDIAN AND ALASKA NATIVES USING ENHANCED DATA INFRASTRUCTURE." The award was made on September 27, 2010 by the Agency for Healthcare Research and Quality (AHRQ), a civilian agency within the U.S. Department of...
The Centers for Disease Control and Prevention (CDC) awarded a $4,455,976 cost-no-fee definitive contract to The Regents of the University of California, San Francisco (UCSF) to develop, implement, and evaluate interventions to improve latent tuberculosis infection (LTBI) identification and treatment among high-risk non-U.S.-born populations in primary care settings. This contract, known as Tuberculosis Epidemiologic Studies Consortium III (TBESC3), has a period of performance from September 29,...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Siris Pharmaceutical Services LLC, a woman-owned small business, to provide tuberculosis (TB) clinical trials management support. The contract has a ceiling value of $2,395,614.70 and is a time and materials contract with a period of performance ending on September 10, 2026. The contract is designated as a total small business set-aside. This contract supports the CDC's efforts to advance TB research...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,434,867.00 definitive cost-no-fee contract to The Johns Hopkins University to support the Tuberculosis Trials Consortium (TBTC). This contract, which does not have a set-aside designation, was awarded on September 18, 2019 and has a completion date of March 17, 2021. The Johns Hopkins University, a private non-profit research university, will provide clinical trial and data coordination services...
This federal contract award, with ID HHSD200201692277C, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Colorado-Denver, doing business as The Regents of the University of Colorado, for the UTIDECIDE program. The $249,708 firm fixed-price definitive contract has an ultimate completion date of September 19, 2017 and was awarded on September 13, 2016. The contract does not have a set-aside designation. The University of Colorado-Denver is a major public...
This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) to the Maryland Department of Health Vital Statistics Administration Division, a U.S. state government entity, to support the Tuberculosis Epidemiology Studies Consortium. The contract has a ceiling value of $4,178,577.57 and runs through September 2021. It is a cost-no-fee contract type, with no set-aside designation. The contract provides for a comparison of tuberculin skin tests (TST) versus...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order contract valued at $246,000.00 to the University of Colorado-Denver, a major public research university, for a project titled "RECTAL STUDY". The contract has an ultimate completion date of January 14, 2028 and was awarded on September 18, 2024. This award appears to be part of a larger Indefinite Delivery Contract (IDC) awarded by the National Institute on Alcohol Abuse and Alcoholism...